NCT03296670View on ClinicalTrials.gov

Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP

PHASE4CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

August 1, 2015

Primary Completion Date

April 28, 2017

Study Completion Date

August 31, 2017

Conditions
ST Segment Elevation Myocardial InfarctionCoronary Slow Flow Phenomenon
Interventions
DRUG

Alprostadil

alprostadil,2ug, delivered by targeted perfusion catheter in the culprit vessel after PCI in STEMI patients with CSFP

DRUG

Nitroglycerin

Nitroglycerin,200ug, delivered by targeted perfusion catheter in the culprit vessel after PCI in STEMI patients with CSFP

Trial Locations (1)

Unknown

Ren Ji Hospital Afflited to School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT03296670 - Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP | Biotech Hunter | Biotech Hunter